These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27055137)

  • 1. Metastatic Renal Cell Carcinoma in the Thyroid Gland and Pancreas Showing Uptake on 68Ga DOTATATE PET/CT Scan.
    Kanthan GL; Schembri GP; Samra J; Roach P; Hsiao E
    Clin Nucl Med; 2016 Jul; 41(7):583-4. PubMed ID: 27055137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor.
    Soydal C; Nak D; Araz M; Demirkazik A; Kucuk NO
    Clin Nucl Med; 2019 Oct; 44(10):795-796. PubMed ID: 31306201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68Ga-DOTATATE Uptake in Solitary Pancreatic Metastasis From Clear Cell Renal Cancer.
    Vamadevan S; Le K; Shen L; Loh H; Mansberg R
    Clin Nucl Med; 2017 Sep; 42(9):700-701. PubMed ID: 28719449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
    Jois B; Asopa R; Basu S
    Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 68Ga-DOTATATE Uptake in a Soft Tissue Metastasis From Clear Cell Renal Cell Cancer.
    Vamadevan S; Le K; Shen L; Stevanovic A; Loh H; Mansberg R
    Clin Nucl Med; 2018 Jan; 43(1):44-45. PubMed ID: 29076916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of
    Tuncel M; Kılıçkap S; Süslü N
    Ann Nucl Med; 2020 Sep; 34(9):663-674. PubMed ID: 32602032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma: a pilot study.
    Almeida LS; Araújo MC; Zantut-Wittmann DE; Assumpção LV; Souza TF; Silva CM; Argenton JL; Santos AO; Mengatti J; Ramos CD; Etchebehere EC
    Nucl Med Commun; 2018 May; 39(5):441-450. PubMed ID: 29543624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary Contralateral Adrenal Metastasis of Renal Cell Carcinoma: 68Ga-DOTATATE PET/CT Findings.
    Filizoglu N; Ozguven S
    Clin Nucl Med; 2022 Jan; 47(1):e41-e42. PubMed ID: 34132679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rate and Clinical Significance of Incidental Thyroid Uptake as Detected by Gallium-68 DOTATATE Positron Emission Tomography/Computed Tomography.
    Nockel P; Millo C; Keutgen X; Klubo-Gwiezdzinska J; Shell J; Patel D; Nilubol N; Herscovitch P; Sadowski SM; Kebebew E
    Thyroid; 2016 Jun; 26(6):831-5. PubMed ID: 27094616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Therapeutic Uptake of Intrathyroid Metastasis of Midgut Neuroendocrine Tumor on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE Imaging.
    Vija Racaru L; Sinigaglia M; Fontaine S; DʼAure D; Courbon F; Dierickx L
    Clin Nucl Med; 2019 Jul; 44(7):e445-e448. PubMed ID: 31021912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
    J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT.
    Ulaner GA; Bodei L
    Clin Nucl Med; 2019 Apr; 44(4):330-331. PubMed ID: 30688738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
    Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC
    J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
    Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
    Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
    Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
    J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How often do we see incidental 68Ga-DOTATATE thyroid uptake in PET/CT in patients with neuroendocrine tumours?
    Kunikowska J; Matyskiel R; Zemczak A; Strzelczyk J; Pawlak D; Królicki L; Kos-Kudła B
    Endokrynol Pol; 2015; 66(3):231-6. PubMed ID: 26136132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
    Ozkan ZG; Kuyumcu S; Uzum AK; Gecer MF; Ozel S; Aral F; Adalet I
    Nucl Med Commun; 2015 Mar; 36(3):242-50. PubMed ID: 25369749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
    Chan M; Schembri GP
    Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytology diagnosis of metastatic clear cell renal cell carcinoma, synchronous to pancreas, and metachronous to thyroid and contralateral adrenal: Report of a case and literature review.
    Bokhari A; Tiscornia-Wasserman PG
    Diagn Cytopathol; 2017 Feb; 45(2):161-167. PubMed ID: 27770513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.